Anthropic's $400M Coefficient Bio acquisition in April now looks like the opening move. Bringing in Jumper signals a serious, funded bet on AI for biology and medicine, not a defensive hire. https://www.implicator.ai/nobel-laureate-john-jumper-leaves-google-deepmind-for-anthropic/
